Dosing

Missed Wegovy Dose: What to Do Next

GLP-1 Companion · 6 min read

Wegovy (semaglutide 2.4 mg) is administered once weekly by subcutaneous injection on the same day each week. When a dose is missed — whether due to travel, forgetting, running out of medication, or any other reason — it is important to follow Novo Nordisk's official guidance rather than improvising. The wrong response to a missed dose can introduce unnecessary risk or disrupt your weight loss progress.

Official Novo Nordisk Guidance for a Missed Wegovy Dose

The prescribing information for Wegovy provides clear, straightforward instructions for a missed dose. These are the official guidelines as published in the FDA-approved labeling:

• If your missed dose is within 5 days of your scheduled injection day: inject the missed dose as soon as you remember.
• If your missed dose is more than 5 days after your scheduled injection day: skip the missed dose entirely. Do not inject it.
• After either scenario, resume your regular weekly schedule on your next scheduled injection day.
• Never inject a double dose to make up for the missed injection.

A Practical Example

Suppose you normally inject Wegovy every Monday. You forget your dose on Monday and realize it on Wednesday. Wednesday is two days after your scheduled day — within the 5-day window — so you inject on Wednesday. Your next scheduled injection is the following Monday (seven days after Wednesday), and you resume your regular Monday schedule from there. If instead you did not remember until Saturday — five days after Monday — you are at the boundary. If it has been exactly five days, you may still be within the window; if it has been six or more days, skip the dose and wait until the following Monday.

Impact on Weight Loss Timeline

A single missed Wegovy dose is unlikely to meaningfully derail your weight loss progress. Semaglutide has a long half-life — approximately one week — meaning that even after missing an injection, meaningful drug levels persist in your system for several additional days. Appetite suppression and GI effects may diminish somewhat in the days following a missed dose, and you may notice increased hunger, but the pharmacological effect does not disappear overnight. Occasional missed doses do not erase prior progress or require restarting at a lower dose.

What If You Miss Multiple Doses in a Row

Missing two or more consecutive doses is a different situation and warrants contacting your prescribing provider. After two to three weeks without semaglutide, drug levels fall substantially and appetite typically returns. Depending on how long the gap has been, your provider may recommend resuming at your current dose or stepping back to the previous dose level to minimize GI side effects during the re-introduction period.

• Missed 1 dose (7 days late): Follow the 5-day rule described above.
• Missed 2 consecutive doses (about 2 weeks late): Contact your provider. Many will have you resume at your current dose, but some prefer stepping back one level.
• Missed 3 or more consecutive doses (3+ weeks late): Resume under provider guidance, likely at a lower dose. Treat this similarly to a short restart protocol.
• Supply gap of 4 or more weeks: Follow the full restart protocol — resume at the lowest dose and re-escalate.

Setting Reminders to Prevent Missed Doses

Consistent weekly dosing is one of the most important factors in treatment success. Establishing a reliable reminder system prevents the majority of missed doses.

1. Set a recurring weekly alarm on your phone labeled "Wegovy injection" for the same day and time each week.
2. Pair the injection with an existing weekly routine — Sunday evening dinner prep, Monday morning routine, or another consistent anchor.
3. Keep your Wegovy pen in a visible, designated location in the refrigerator (Wegovy should be refrigerated at 36°F to 46°F / 2°C to 8°C when not in use).
4. Consider a medication tracking app that logs each injection and sends reminders.
5. If you travel frequently, plan ahead: Wegovy can be stored at room temperature (up to 77°F / 25°C) for up to 28 days after first use, making travel manageable.
6. Ask a partner, family member, or friend to serve as a secondary reminder for the first few months of treatment.

Can You Change Your Injection Day?

Yes. If your current injection day consistently conflicts with your schedule — making missed doses more likely — you can change to a different day of the week. The prescribing information allows for this as long as the new injection day maintains at least two days from the prior injection. For example, if you move from Monday to Wednesday, ensure your last Monday injection was at least two days before the Wednesday dose. Once established on the new day, continue weekly on that day.

When to Call Your Prescriber

Most single missed doses do not require a call to your provider. However, you should contact your prescriber if you have missed two or more consecutive doses and are uncertain about how to safely resume, if you ran out of medication and there will be a gap before your next supply arrives, if you are experiencing increased side effects after resuming an overdue dose, or if missing doses is becoming a pattern that may indicate a tolerance or side effect issue that needs to be addressed.

Novo Nordisk's prescribing information states clearly: "If a dose is missed, administer as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day."

Key Takeaways

A missed Wegovy dose is manageable with the right protocol. Within 5 days of the scheduled date: inject immediately and resume your regular weekly schedule. More than 5 days late: skip the missed dose and resume on the next scheduled day. Never double dose. One missed dose will not erase your progress given semaglutide's long half-life. Multiple missed doses warrant provider guidance on whether and how to safely resume. Prevention through consistent reminders is the best strategy.

Sources

• Wegovy (semaglutide) Prescribing Information. Novo Nordisk.
• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.